This forum post is hidden because you have chosen to ignore DrMK. Show Details
This forum post is hidden because you have submitted an abuse report against it. Show Details
A study in the Lancet may not settle the debate but says there is benefit for people who are not at high risk of heart disease or stroke from taking statins. NICE currently recomends statins for people with CVD or those with a 20% risk of developing CVD within 10 years.It's a big meta analysis
it included 22 trials of statin versus control (n=134537; mean LDL cholesterol difference 1.08 mmol/L; median follow-up 4.8 years) and five trials of more versus less statin (n=39612; difference 0.51 mmol/L; 5.1 years).
It concludes; In individuals with 5-year risk of major vascular events lower than 10%, each 1 mmol/L reduction in LDL cholesterol produced an absolute reduction in major vascular events of about 11 per 1000 over 5 years. This benefit greatly exceeds any known hazards of statin therapy. Under present guidelines, such individuals would not typically be regarded as suitable for LDL-lowering statin therapy. The present report suggests, therefore, that these guidelines might need to be reconsidered
Would you agree? I suppose if NICE says so it would be ok although I am not sure what will happen re the CCGs if they have to pay for it?